Back to all news
AI Model Predicts Microsatellite Instability and Immunotherapy Response from Histology
Yonsei University researchers introduced MSI-SEER, an AI model for MSI and immunotherapy response prediction from histology images of gastric and colorectal cancers.
Key Details
- 1MSI-SEER uses deep Gaussian process modeling to analyze H&E-stained whole-slide images.
- 2The model integrates uncertainty quantification, providing a Bayesian Confidence Score for each prediction.
- 3MSI-SEER flags uncertain cases for human review to enhance reliability and safety.
- 4Validated on large, racially diverse datasets, it achieved state-of-the-art MSI prediction accuracy.
- 5The model also predicts immune checkpoint inhibitor (ICI) response, integrating tumor MSI status and stroma-to-tumor ratio.
- 6Published in npj Digital Medicine on May 19, 2025.
Why It Matters
This innovation demonstrates the power of AI in pathology to provide clinically actionable predictions and to integrate uncertainty for safer AI-human collaboration in cancer diagnosis and therapy selection. The approach may serve as a model for broader use of AI in precision oncology workflows.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.